Pacific Biosciences Of California reported $44.64M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
Bruker USD 838.5M 15.1M Jun/2026
Danaher USD 6.3B 350M Jun/2026
General Electric Aerospace USD 12.63B 1.03B Jun/2026
Illumina USD 1.16B 70M Jun/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 620M 104M Mar/2026
Revvity USD 729.68M 18.68M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Standard Biotools USD 21.1M 2.7M Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Waters USD 1.64B 370M Jun/2026